Company: SMNR
Filing Date: 2025-09-26
Form Type: 8-K
Source: 0001193125-25-220455
Chunk: 12

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-09-26
Form: 8-K
Item: Item 9.01
Chunk 12
---
Item 9.01.      Financial Statements and Exhibits.  

(a) Financial statements of businesses acquired.

The unaudited condensed consolidated financial statements of Denali as of and for the three and six months ended June 30, 2025 and 2024, and the related notes thereto beginning on page 1 of Denali’s Quarterly Report on Form10-Q, filed with the SEC on August 15, 2025 (the “ Form10-Q”), are incorporated herein by reference. These unaudited condensed consolidated financial statements should be read in conjunction with the historical audited financial statements of Denali for the years ended December 31, 2024 and 2023 and the related notes included in the Proxy Statement/Prospectus beginning on pageF-2thereof, which are incorporated herein by reference.